Yanik, Gregory A <br/><br/>
The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.  [electronic resource] 

 -  Blood  Oct 2008 
 - 3073-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2008-03-143412  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Child<br/>Child, Preschool<br/>Etanercept<br/>Female<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Immunoglobulin G--administration & dosage<br/>Immunosuppressive Agents--therapeutic use<br/>Infant<br/>Inflammation<br/>Male<br/>Middle Aged<br/>Pneumonia--drug therapy<br/>Receptors, Tumor Necrosis Factor--administration & dosage<br/>Syndrome<br/>Transplantation, Homologous--adverse effects<br/>Treatment Outcome